Suter Melissa A, Sangi-Haghpeykar Haleh, Showalter Lori, Shope Cynthia, Hu Min, Brown Kathleen, Williams Sarah, Harris R Alan, Grove Kevin L, Lane Robert H, Aagaard Kjersti M
Division of Maternal-Fetal Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Mol Endocrinol. 2012 Dec;26(12):2071-80. doi: 10.1210/me.2012-1214. Epub 2012 Sep 26.
Thyroid hormone (TH) is an essential regulator of both fetal development and energy homeostasis. Although the association between subclinical hypothyroidism and obesity has been well studied, a causal relationship has yet to be established. Using our well-characterized nonhuman primate model of excess nutrition, we sought to investigate whether maternal high-fat diet (HFD)-induced changes in TH homeostasis may underlie later in life development of metabolic disorders and obesity. Here, we show that in utero exposure to a maternal HFD is associated with alterations of the fetal thyroid axis. At the beginning of the third trimester, fetal free T(4) levels are significantly decreased with HFD exposure compared with those of control diet-exposed offspring. Furthermore, transcription of the deiodinase, iodothyronine (DIO) genes, which help maintain thyroid homeostasis, are significantly (P < 0.05) disrupted in the fetal liver, thyroid, and hypothalamus. Genes involved in TH production are decreased (TRH, TSHR, TG, TPO, and SLC5A5) in hypothalamus and thyroid gland. In experiments designed to investigate the molecular underpinnings of these observations, we observe that the TH nuclear receptors and their downstream regulators are disrupted with maternal HFD exposure. In fetal liver, the expression of TH receptor β (THRB) is increased 1.9-fold (P = 0.012). Thorough analysis of the THRB promoter reveals a maternal diet-induced alteration in the fetal THRB histone code, alongside differential promoter occupancy of corepressors and coactivators. We speculate that maternal HFD exposure in utero may set the stage for later in life obesity through epigenomic modifications to the histone code, which modulates the fetal thyroid axis.
甲状腺激素(TH)是胎儿发育和能量稳态的重要调节因子。尽管亚临床甲状腺功能减退与肥胖之间的关联已得到充分研究,但因果关系尚未确立。利用我们特征明确的过量营养非人类灵长类动物模型,我们试图研究母体高脂饮食(HFD)引起的TH稳态变化是否可能是后期代谢紊乱和肥胖发生发展的基础。在此,我们表明子宫内暴露于母体HFD与胎儿甲状腺轴的改变有关。在妊娠晚期开始时,与对照饮食喂养的后代相比,暴露于HFD的胎儿游离T4水平显著降低。此外,有助于维持甲状腺稳态的脱碘酶、碘甲状腺原氨酸(DIO)基因在胎儿肝脏、甲状腺和下丘脑的转录受到显著(P < 0.05)破坏。下丘脑和甲状腺中参与TH产生的基因(TRH、TSHR、TG、TPO和SLC5A5)减少。在旨在研究这些观察结果分子基础的实验中,我们观察到母体HFD暴露会破坏TH核受体及其下游调节因子。在胎儿肝脏中,TH受体β(THRB)的表达增加了1.9倍(P = 0.012)。对THRB启动子的深入分析揭示了母体饮食诱导的胎儿THRB组蛋白编码改变,以及共抑制因子和共激活因子在启动子上的不同占据情况。我们推测子宫内母体HFD暴露可能通过对组蛋白编码的表观基因组修饰为后期肥胖奠定基础,这种修饰会调节胎儿甲状腺轴。